The interaction of soluble TIE2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients

Shock

Volumn 33, Issue 3, 2010, Pages 263-268

  Van Der Heijden, Melanie ^a   Van Nieuw Amerongen, Geerten P ^a   Van Hinsbergh, Victor W M ^a   Groeneveld, Ab Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; GALLIUM 67; TRANSFERRIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; LUNG BLOOD VESSEL; MALE; PROTEIN PROTEIN INTERACTION; SEPSIS;

ACUTE LUNG INJURY; AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CAPILLARY PERMEABILITY; CRITICAL ILLNESS; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; LUNG; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; RECEPTOR, TIE-2; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TRANSFERRIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77149131838     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181b2f978     Document Type: Article

References (36)

1. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293-301, 1995.
2. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3:356-370, 2006.
3. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, Mostoslavsky G, Ingber DE, Sukhatme VP: Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 282:23910-23918, 2007.
4. Findley CM, Cudmore MJ, Ahmed A, Kontos CD: VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27:2619-2626, 2007.
5. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997.
6. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG: The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal auto-crine loop mechanism. J Cell Sci 118:771-780, 2005.
7. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RN, et al.: Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 175:1014-1026, 2007.
8. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4:1525-1537, 2007.
9. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD: Angiopoietin-1 protects the adult vascula-ture against plasma leakage. Nat Med 6:460-463, 2000.
10. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C: Protective role of angiopoietin-1 in endotoxic shock. Circulation 111:97-105, 2005.
11. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM: Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in endothelium. Mol Cell Biol 29:2011-2022, 2009.
12. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al.: Hyperoxia causes angiopoietin 2Ymediated acute lung injury and necrotic cell death. Nat Med 12:1286-1293, 2006.
13. Daly C, Pasnikowski E, Burova E, Wong V, Aldrich TH, Griffiths J, Ioffe E, Daly TJ, Fandl JP, Papadopoulos N, et al.: Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 103:15491-15496, 2006.
14. Van der Heijden M, Van Nieuw Amerongen GP, Chedamni S, Van Hinsbergh VWM, Groeneveld ABJ: The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury. Expert Opin Ther Targets 13:39-53, 2009.
15. Van der Heijden M, Van Nieuw Amerongen GP, Koolwijk P, Van Hinsbergh VWM, Groeneveld ABJ: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 63:903-909, 2008.
16. 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. Crit Care Med 24:1467-1472, 1996.
17. Sinclair DG, Braude S, Haslam PL, Evans TW: Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. Chest 106:535-539, 1994.
18. Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, Sotiropoulou C, Zakynthinos S, Armaganidis A, Papapetropoulos A, et al.: Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med 35:199-206, 2006.
19. Findley CM, Mitchell RG, Duscha BD, Annex BH, Kontos CD: Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 52:387-393, 2008.
20. Reusch P, Barleon B, Weindel K, Martiny-Baron G, Godde A, Siemeister G, Marme D: Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 4:123-131, 2001.
21. Chung NA, Makin AJ, Lip GY: Measurement of the soluble angiopoietin receptor Tie-2 in patients with coronary artery disease: development and application of an immunoassay. Eur J Clin Invest 33:529-535, 2003.
22. Harris AL, Reusch P, Barleon B, Hang C, Dobbs N, Marme D: Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. Clin Cancer Res 7:1992-1997, 2001.
23. Pousa ID, Mate J, Salcedo-Mora X, Abreu MT, Moreno-Otero R, Gisbert JP: Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients. Inflamm Bowel Dis 14:61-67, 2008.
24. Schliemann C, Bieker R, Thoennissen N, Gerss J, Liersch R, Kessler T, Buchner T, Berdel WE, Mesters RM: Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia 21:1901-1906, 2007.
25. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY: Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor Tie-2 levels in congestive heart failure. J Am Coll Cardiol 43:423-428, 2004.
26. Nadar SK, Blann A, Beevers DG, Lip GY: Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 258:336-343, 2005.
27. Lee KW, Lip GY, Blann AD: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor Tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 110:2355-2360, 2004.
28. Groeneveld ABJ, Verheij J: Extravascular lung water to blood volume ratios as measures of permeability in sepsis-induced ALI/ARDS. Intensive Care Med 32:1315-1321, 2006.
29. Verheij J, Van Lingen A, Raijmakers PG, Rijnsburger ER, Veerman DP, Wisselink W, Girbes AR, Groeneveld ABJ: Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 96:21-30, 2006.
30. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 138:720-723, 1988.
31. Gallagher DC, Parikh SM, Balonov K, Miller A, Gautam S, Talmor D, Sukhatme VP: Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 29:656-661, 2008.
32. Giuliano JS Jr, Lahni PM, Bigham MT, Manning PB, Nelson DP, Wong HR, Wheeler DS: Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass. Intensive Care Med 34:1851-1857, 2008.
33. Giamarellos-Bourboulis EJ, Kanellakopoulou K, Pelekanou A, Tsaganos T, Kotzampassi K: Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity. Cytokine 44:310-313, 2008.
34. Siner JM, Bhandari V, Engle KM, Elias JA, Siegel MD: Elevated serum angiopoietin-2 levels are associated with increased mortality in sepsis. Shock 31:348-353, 2008.
35. Giuliano JS Jr, Lahni PM, Harmon K, Wong HR, Doughty LA, Carcillo JA, Zingarelli B, Sukhatme VP, Parikh SM, Wheeler DS: Admission angiopoietin levels in children with septic shock. Shock 28:650-654, 2007.
36. Wong MP, Chan SY, Fu KH, Leung SY, Cheung N, Yuen ST, Chung LP: The angiopoietins, Tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to nonYsmall cell lung carcinomas. Lung Cancer 29:11-22, 2000.